Great progress in synthetic methodologies of short half-life radiopharmaceuticals for PET has been made. This article aims to summarize the synthetic methodologies and progress of fluorine-18
carbon-11
oxygen-15 and nitrogen-13 labelled radiopharmaceuticals
with special emphasis on the radiochemistry of those labelled with carbon-11 and fluorine-18.